FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

421026006: Conventional release oral tablet (dose form)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2616657012 Oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3636015013 Conventional release oral tablet (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3636016014 Conventional release oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module


3 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conventional release oral tablet Is a Tablet false Inferred relationship Existential restriction modifier
Conventional release oral tablet Is a Oral dose form true Inferred relationship Existential restriction modifier
Conventional release oral tablet Has dose form intended site Oral true Inferred relationship Existential restriction modifier
Conventional release oral tablet Has dose form administration method Swallow true Inferred relationship Existential restriction modifier
Conventional release oral tablet Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Conventional release oral tablet Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Conventional release oral tablet Has basic dose form Tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Ascorbic acid 100mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Ascorbic acid 200mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Ascorbic acid 500mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Aspirin 300mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Aspirin 75mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Atenolol 25mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Atenolol 50mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Atenolol 100mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Azathioprine 25mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Azathioprine 50mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Baclofen 10mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Bendroflumethiazide 5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Betahistine 8mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Bezafibrate 200mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Bisacodyl 5mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Bisoprolol 1.25mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Calcort 6mg tablets (Lexon (UK) Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Busulfan 2mg tablets (Aspen Pharma Trading Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Nortriptyline 10mg tablets (Teva UK Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Nortriptyline 25mg tablets (Teva UK Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Bisoprolol 2.5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Bisoprolol 3.75mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Bisoprolol 5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Bisoprolol 10mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Bromocriptine 2.5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Bumetanide 5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Buspirone 5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Buspirone 10mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Cabergoline 500microgram tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Cabergoline 1mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Calcium folinate 15mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Calcium lactate 300mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Carbamazepine 100mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form False Conventional release oral tablet Inferred relationship Existential restriction modifier
Carbamazepine 200mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form False Conventional release oral tablet Inferred relationship Existential restriction modifier
Carvedilol 3.125mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Carvedilol 6.25mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Carvedilol 12.5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Cefuroxime 250mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Celiprolol 200mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Cetirizine 10mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Chlorphenamine 4mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Chlorpromazine 25mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Cilostazol 100mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Cimetidine 800mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Clopidogrel 75mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Co-amilofruse 10mg/80mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Co-amilozide 2.5mg/25mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Co-amoxiclav 875mg/125mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Co-codamol 8mg/500mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Co-dydramol 10mg/500mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Codeine 15mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Codeine 30mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Cyanocobalamin 50microgram tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Cyproterone 100mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Dapsone 50mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Dapsone 100mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Desloratadine 5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Desogestrel 75microgram tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Diazepam 2mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Diazepam 5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Digoxin 125microgram tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Digoxin 250microgram tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Domperidone 10mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Donepezil 5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Almotriptan 12.5mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Aripiprazole 5mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Aripiprazole 10mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Aripiprazole 15mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Calcium and Ergocalciferol tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg caplets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Cilazapril 5mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Cilostazol 100mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Adenuric 80mg tablets (Waymade Healthcare Plc) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Azilect 1mg tablets (Waymade Healthcare Plc) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Clobazam 10mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Clonidine 25microgram tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Brilique 90mg tablets (Waymade Healthcare Plc) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Co-amilofruse 5mg/40mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Co-amilofruse 10mg/80mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Dexamethasone 500microgram tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Diclofenac potassium 50mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Dicycloverine 10mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Dicycloverine 20mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Eplerenone 25mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Eplerenone 50mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Eprosartan 300mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Eprosartan 400mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Escitalopram 5mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Escitalopram 10mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Escitalopram 20mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Fenofibrate micronised 160mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Ferrous fumarate 210mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier

Start Previous Page 325 of 345 Next End


This concept is not in any reference sets

Back to Start